Soc. Generale Knock-Out TGT/ DE000SU2BQ77 /
2024-06-04 1:26:12 PM | Chg.-0.120 | Bid1:38:03 PM | Ask1:38:03 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.180EUR | -2.79% | 4.190 Bid Size: 2,000 |
4.280 Ask Size: 2,000 |
Target Corp | 106.1015 USD | 2078-12-31 | Call |
GlobeNewswire
1:30 PM
DeFi Technologies Subsidiary Valour Inc. Expands Collaboration with justTRADE; 1Valour STOXX Bitcoin...
GlobeNewswire
1:30 PM
BridgeBio Announces Durable Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondr...
Newsfile Corp
1:18 PM
KEMO SAAS Launches All-In-One Marketing & Sales Platform to Transform Business Workflows
GlobeNewswire
1:00 PM
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
1:00 PM
Mobilicom CEO Oren Elkayam to Advocate for Uncrewed Systems at AUVSI's Hill Day in Washington, D.C.
GlobeNewswire
1:00 PM
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in...
GlobeNewswire
1:00 PM
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...
GlobeNewswire
1:00 PM
ConnectWise Introduces Sidekick for Security: Transforming Cyber Defense with AI
GlobeNewswire
1:00 PM
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...
GlobeNewswire
1:00 PM
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital ...
GlobeNewswire
1:00 PM
ConnectWise Introduces AI-Powered ConnectWise Security360™, Next-Generation Cybersecurity Solution
GlobeNewswire
1:00 PM
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During...